We want to hear from you if, together, we can speed up our pathway from the lab to the patient, and reduce barriers to clinical uptake of innovative treatments.
We want to partner with organisations who wish to increase adoption of advanced therapeutics such as gene therapies.
We want to hear from you if, together, we can speed up our pathway from the lab to the patient, and reduce barriers to clinical uptake of innovative treatments.
We want to partner with diverse organisations ranging from:
We are experienced in working with external partners, including industry, tailoring each collaboration to deliver mutual benefits.
We are seeking partner organisations:
Find out the benefits of collaborating with us and becoming a partner organisation.
Jointly develop new tools, methods and complementary intellectual property (IP) to existing technologies aligned to clinical needs.
Sharing of materials, access to specialist facilities and technology platforms , licensing of intellectual property (IP), tools and methods.
Knowledge transfer and upskilling of staff through staff exchanges, secondments, visits, and training to build long-term capability.
Joint bids for translational research and development funding on competitive funding calls (e.g., UKRI, Innovate UK, Horizon Europe, NIHR) and targeted philanthropic funding opportunities.
Inputting in activities (e.g. working groups) that aim to address pain points for the adoption of advanced therapeutics to the benefit of the wider sector and patients.
Communicating our work and enabling the dissemination of key outputs to key audiences.
If you are interested in collaborating with us, get in touch.
Head of Operations- Advanced Therapeutics Hub
This article was published on